Site planning risk brief

Retention permission for as constructed elevation modification, works consist of application of waterproof silicone based render system to a previously concrete brick facade at

For development consisting of erecting a roof covering to the existing open yard, consisting of a steel frame structure and profiled metal cladding along with a security shutter to form a semi enclosed storage yard along with associated siteworks to facilitate the development.

Change of use from office use (ancillary to a manufacturing/storage facility) to a managed mixed office use over two-storeys to the front of existing building and retention permission for new signage and elevational changes to front and side of existing building together with permission for a change of use from a manufacturing/storage facility to a sub-divided, centrally managed, mixed use development consisting of: manufacturing/storage units, pharmaceutical research & development incubation hubs together with offices, to accommodate science & technology sales, enterprise & training, innovation and specialist uses, and permission for elevational changes, internal modifications, connection to existing public services and all associated site works

A boundary wall and fence and associated works

EXTENSION OF DURATION OF Planning Ref. 13500060: Planning permission sought by Teva Pharmaceuticals Ireland for extension consisting of warehousing, loading bays, plant rooms, associated car parking and landscaping. The floor area is 1,996m2, the building is 17.1 meters high and the development is located

For a single storey warehouse extension located between existing Keltech buildings over their existing car park with all ancillary site development works at